HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
AIRE
autoimmune regulator
Chromosome 21 · 21q22.3
NCBI Gene: 326Ensembl: ENSG00000160224.18HGNC: HGNC:360UniProt: O43918
225PubMed Papers
21Diseases
0Drugs
228Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
positive regulation of transcription by RNA polymerase IIzinc ion bindinghistone bindingidentical protein bindingautoimmune polyendocrine syndrome type 1Autoimmune polyendocrinopathy type 1autoimmune polyendocrinopathygenetic disorder
✦AI Summary

AIRE is a transcription factor essential for central immune tolerance, primarily expressed in medullary thymic epithelial cells (mTECs) 1. It regulates expression of tissue-restricted antigens (TRAs)—self-proteins normally confined to peripheral organs—enabling their presentation to developing thymocytes via MHC-I and MHC-II molecules 1. This ectopic expression promotes negative selection of self-reactive T cells and regulatory T cell (Treg) development, preventing autoimmunity 2. AIRE functions as a histone modification sensor, binding to A/T-rich DNA sequences and selectively interacting with unmodified histone H3 to regulate chr21 accessibility 1. Beyond thymic roles, AIRE controls medullary dendritic cell accumulation and lymphocyte migration through XCL1 and chemokine ligand regulation 1. Extrathymic AIRE-expressing cells also contribute to peripheral tolerance mechanisms 3. Disruption of AIRE causes autoimmune polyendocrine syndrome type-1 (APECED/APS-1), an autosomal recessive disorder characterized by impaired T cell negative selection, reduced Treg function, and pathogenic autoantibody production 4. Approximately 100 mutations have been identified, with certain mutations exhibiting dominant-negative effects in milder autoimmune diseases including vitiligo and thyroiditis 5. Evidence suggests excessive interferon-γ response may drive organ-specific damage in APECED, potentially amenable to JAK inhibitor therapy 4.

Sources cited
1
AIRE regulates tissue-restricted antigens in mTECs and their presentation to thymocytes
PMID: 26084028
2
AIRE promotes negative selection and prevents self-reactive T cell escape
PMID: 19302042
3
Emerging insights into AIRE biology including extrathymic AIRE-expressing cells and Janus cells
PMID: 38360547
4
AIRE mutations cause APECED with impaired tolerance; JAK inhibitors as potential therapy
PMID: 39440452
5
Approximately 100 AIRE mutations identified; some exhibit dominant-negative effects in common autoimmune diseases
PMID: 27504588
Disease Associationsⓘ21
autoimmune polyendocrine syndrome type 1Open Targets
0.85Strong
Autoimmune polyendocrinopathy type 1Open Targets
0.84Strong
autoimmune polyendocrinopathyOpen Targets
0.59Moderate
genetic disorderOpen Targets
0.47Moderate
rheumatoid arthritisOpen Targets
0.47Moderate
neurodegenerative diseaseOpen Targets
0.43Moderate
adrenocortical insufficiencyOpen Targets
0.42Moderate
Genetic chronic primary adrenal insufficiencyOpen Targets
0.38Weak
primary adrenal insufficiencyOpen Targets
0.37Weak
alternating hemiplegia of childhoodOpen Targets
0.37Weak
Cytomegalic congenital adrenal hypoplasiaOpen Targets
0.37Weak
familial isolated hypoparathyroidism due to impaired PTH secretionOpen Targets
0.37Weak
X-linked adrenal hypoplasia congenitaOpen Targets
0.37Weak
immunodeficiency diseaseOpen Targets
0.34Weak
hypoparathyroidismOpen Targets
0.33Weak
vitamin B12 deficiencyOpen Targets
0.30Weak
type 1 diabetes mellitusOpen Targets
0.29Weak
device complicationOpen Targets
0.22Weak
cardiovascular diseaseOpen Targets
0.11Weak
neoplasmOpen Targets
0.09Suggestive
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasiaUniProt
Pathogenic Variants228
NM_000383.4(AIRE):c.967_979del (p.Leu323fs)Pathogenic
Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia|Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder|Retinal disorder|Autoimmune polyendocrinopathy
★★☆☆2026→ Residue 323
NM_000383.4(AIRE):c.798+1G>APathogenic
Polyglandular autoimmune syndrome, type 1|AIRE-related disorder
★★☆☆2026
NM_000383.4(AIRE):c.132+1_132+3delinsCTPathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2026
NM_000383.4(AIRE):c.517C>T (p.Gln173Ter)Pathogenic
Polyglandular autoimmune syndrome, type 1|not provided
★★☆☆2026→ Residue 173
NM_000383.4(AIRE):c.254A>G (p.Tyr85Cys)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2026→ Residue 85
NM_000383.4(AIRE):c.769C>T (p.Arg257Ter)Pathogenic
Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder|Inborn genetic diseases|Retinal disorder
★★☆☆2026→ Residue 257
NM_000383.4(AIRE):c.62C>T (p.Ala21Val)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2026→ Residue 21
NM_000383.4(AIRE):c.415C>T (p.Arg139Ter)Pathogenic
Polyglandular autoimmune syndrome, type 1|not provided
★★☆☆2026→ Residue 139
NM_000383.4(AIRE):c.173C>G (p.Ala58Gly)Pathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2026→ Residue 58
NM_000383.4(AIRE):c.232T>C (p.Trp78Arg)Pathogenic
Polyglandular autoimmune syndrome, type 1|not provided
★★☆☆2025→ Residue 78
NM_000383.4(AIRE):c.1095+2T>CPathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2025
NM_000383.4(AIRE):c.1616C>T (p.Pro539Leu)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1|AIRE-related disorder
★★☆☆2025→ Residue 539
NM_000383.4(AIRE):c.44G>T (p.Arg15Leu)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2025→ Residue 15
NM_000383.4(AIRE):c.83T>C (p.Leu28Pro)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2025→ Residue 28
NM_000383.4(AIRE):c.995+3_995+5delinsTATPathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2025
NM_000383.4(AIRE):c.349del (p.Ala117fs)Pathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2025→ Residue 117
NM_000383.4(AIRE):c.798dup (p.Gly267fs)Pathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2025→ Residue 267
NM_000383.4(AIRE):c.1249dup (p.Leu417fs)Pathogenic
Polyglandular autoimmune syndrome, type 1|not provided|Inborn genetic diseases
★★☆☆2025→ Residue 417
NM_000383.4(AIRE):c.1265del (p.Pro422fs)Pathogenic
not provided|Polyglandular autoimmune syndrome, type 1
★★☆☆2025→ Residue 422
NM_000383.4(AIRE):c.1203_1278+28delLikely pathogenic
Polyglandular autoimmune syndrome, type 1
★★☆☆2025
View on ClinVar ↗
Related Genes
CREBBPProtein interaction99%H3-3BProtein interaction98%H3C13Protein interaction95%H3C14Protein interaction94%H3-3AProtein interaction94%EGLN2Protein interaction92%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
3%
Ovary
1%
Liver
1%
Lung
1%
Heart
0%
Gene Interaction Network
Click a node to explore
AIRECREBBPH3-3BH3C13H3C14H3-3AEGLN2
PROTEIN STRUCTURE
Preparing viewer…
PDB1XWH · NMR
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.17LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.92 [0.73–1.17]
RankingsWhere AIRE stands among ~20K protein-coding genes
  • #1,801of 20,598
    Most Researched225 · top 10%
  • #284of 5,498
    Most Pathogenic Variants228 · top 10%
  • #12,229of 17,882
    Most Constrained (LOEUF)1.17
Genes detectedAIRE
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
Aire in Autoimmunity.
PMID: 38360547
Annu Rev Immunol · 2024
1.00
2
Thymus and autoimmunity.
PMID: 33537838
Semin Immunopathol · 2021
0.90
3
Generation of functional thymic organoids from human pluripotent stem cells.
PMID: 36963390
Stem Cell Reports · 2023
0.80
4
Projection of an immunological self shadow within the thymus by the aire protein.
PMID: 12376594
Science · 2002
0.80
5
Aire.
PMID: 19302042
Annu Rev Immunol · 2009
0.70